Eligibility Criteria

To be included in the ACURATE IDE Trial, patients must be diagnosed with severe aortic stenosis, determined to be TAVR-eligible by their heart team, and treatable with an available size of both a test and the control device in the randomized cohorts. All surgical risk levels, including the low risk population, are eligible under the FDA approval of the modified trial design.

For the full list of requirements and considerations, visit the Eligibility Criteria tab of the ACURATE IDE Trial page on ClinicalTrials.gov.